Torii Pharmaceutical Co., Ltd.
TRXPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $209,135,061,679,672 | $187,345,612,497,371 | $174,208,804,057,239 | $158,687,955,238,046 |
| - Cash | $3,319,000 | $5,004,000 | $20,420,000 | $27,374,000 |
| + Debt | $429,000 | $244,000 | $524,000 | $486,000 |
| Enterprise Value | $209,135,058,789,672 | $187,345,607,737,371 | $174,208,784,161,239 | $158,687,928,350,046 |
| Revenue | $60,425,000 | $54,638,000 | $48,894,000 | $46,987,000 |
| % Growth | 10.6% | 11.7% | 4.1% | – |
| Gross Profit | $26,707,000 | $22,758,000 | $23,378,000 | $24,339,000 |
| % Margin | 44.2% | 41.7% | 47.8% | 51.8% |
| EBITDA | $7,133,000 | $6,052,000 | $5,975,000 | $5,047,000 |
| % Margin | 11.8% | 11.1% | 12.2% | 10.7% |
| Net Income | $5,042,000 | $4,119,000 | $3,944,000 | $3,374,000 |
| % Margin | 8.3% | 7.5% | 8.1% | 7.2% |
| EPS Diluted | 179.46 | 146.57 | 140.38 | 120.11 |
| % Growth | 22.4% | 4.4% | 16.9% | – |
| Operating Cash Flow | $3,639,000 | -$3,123,000 | $2,420,000 | -$156,000 |
| Capital Expenditures | -$180,000 | -$216,000 | -$281,000 | -$374,000 |
| Free Cash Flow | $3,459,000 | -$3,339,000 | $2,139,000 | -$530,000 |